Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 1019 composition records across product categories including Industrial products, Construction and building materials, Pesticides.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of SUCROSE in our catalog (epa_cpdat).
Products
1,019
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Canonical allergen markers detected on this ingredient. Each row is derived from the ingredient’s name or synonyms matching a known allergen class — useful when scanning a label for a specific allergy context.
Source: chemindex_name_match
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 1019 composition records across product categories including Industrial products, Construction and building materials, Pesticides. EPA CPDat classifies this chemical for functional uses including Humectant, Softener and conditioner, Binder.
US
FDA
Rigoni di Asiago - Nocciolata bio
Rigoni di Asiago
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: BUCCAL; Dosage form: TABLET; Potency: 109 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTABLE, LIPOSOMAL; Maximum daily exposure: 7560 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 1950 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 970 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: 900 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 2000 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: NA
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION, LIPOSOMAL; Potency: 9.4 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 3568 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 59.8 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Maximum daily exposure: 86 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 955 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 619 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 4800 mg
US
FDA
Route: ORAL; Dosage form: ELIXIR; Maximum daily exposure: 18000 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Maximum daily exposure: 42596 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 31885 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: LIQUID; Maximum daily exposure: 37500 mg
US
FDA
Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 27768 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 38666 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 40017 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 70000 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 48209 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 5400 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 3750 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 46400 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4249 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 7258 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 516.42 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 295.33 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 284.54 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 145 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 119.12 mg
US
FDA
Route: RECTAL; Dosage form: SOLUTION; Potency: 35.42 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 47.75 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 308 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 1 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 109 mg
US
FDA
Route: TRANSMUCOSAL; Dosage form: LOZENGE; Maximum daily exposure: 1255 mg
US
FDA
FDA NDC lists this ingredient in 48 active drug products and 56 total products.
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
FDA
openFDA substance registry classifies this ingredient as chemical.
US
USDA FoodData Central
Observed in 5 USDA branded foods including 1.5OZ LITEHOUSE CHUNKY BLUE CHEESE DRESSING, 1.5OZ LITEHOUSE JALAPENO RANCH DRESSING, 1.5oz LITEHOUSE CAESAR DRESSING.